It perhaps indicated that DCIS occurring in carriers of BRCA1 mutations are also more likely to be ER‐negative, PR‐negative, HER2 receptor‐negative, and have a basal phenotype. The gene discussed is BRCA1; the disease is ductal breast carcinoma in situ.